After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ATYR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Atyr Pharma Inc is $253.25M. A total of 1.7 million shares were traded on the day, compared to an average of 1.33M shares.
In the most recent transaction, Gross Jane A bought 3,750 shares of ATYR for 4.00 per share on Mar 17 ’25. After the transaction, the Director now owns 9,750 company shares. In a previous transaction on Feb 04 ’25, Broadfoot Jill Marie sold 1,254 shares at 3.78 per share. ATYR shares that Chief Financial Officer owns now total 31,763.
Among the insiders who sold shares, DENYES NANCY disposed of 899 shares on Feb 04 ’25 at a per-share price of $3.78. This resulted in the General Counsel holding 26,555 shares of ATYR after the transaction. In another insider transaction, SCHIMMEL PAUL bought 52,300 shares at $1.93 per share on Jul 24 ’24. Company shares held by the Director now total 413,023.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ATYR has a high of $4.66 and a low of $1.42.
As of this writing, ATYR has an earnings estimate of -$0.19 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.17 per share and a lower estimate of -$0.25.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ATYR’s latest balance sheet shows that the firm has $107.91M in Cash & Short Term Investments as of fiscal 2021. There were $1.38M in debt and $6.01M in liabilities at the time. Its Book Value Per Share was $0.83, while its Total Shareholder’s Equity was $109.13M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ATYR is Buy with a score of 4.86.
